Specific METTL3 knockout in macrophages increases M1- and M2-like TAMs and promotes Treg enrichment into tumours, establishing an immune-suppressive TIME and limiting the efficacy of PD-1 blockade in melanoma. The gene discussed is METTL3; the disease is neoplasm.